The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1

NCT05143281 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Cataract

Interventions

DRUG: Dexamethasone 0.4 MG [Dextenza]

Sponsor

Grene Vision Group

Collaborators

[object Object]